Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NDLX Health Sciences is a private U.S. health sciences affiliate of The Herrick Company focused on technologies intended to enhance endogenous regenerative processes and improve healthy aging and longevity. The company appears to be working primarily in neurodegeneration, dementia, cardiac recovery, aging biology, and related translational research rather than in a traditional drug-development model. Publicly available information indicates that NDLX has been involved in studies spanning pulsed electromagnetic field technology, liver biology, aging, and cancer models, and has collaborated with external research institutions to move promising approaches toward the clinic. Its work sits at the intersection of biotech, medical technology, and longevity-oriented translational science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NDLX Health Sciences.